Aragona C, Bohnet H G, Friesen H G
Acta Endocrinol (Copenh). 1977 Feb;84(2):402-9. doi: 10.1530/acta.0.0840402.
Specific binding sites for prolactin (PRL) and gonadotrophins on ventral and dorsolateral prostate as well as on Leydig cells and tubules of testes of rats at different ages were examined. The binding sites for PRL were found in greatest number in ventral prostate and in Leydig cells. LH binding sites were also more numerous than FSH binding sites in the latter. FSH sites were greater than LH sites in tubular preparations obtained from the testis. Specific binding (SB) of PRL in the Leydig cells reached a maximum at 45 days (4%) and in the case of LH a maximum of 12% was obtained at 70 days. In both preparations SB of FSH exhibited a plateau between 20 and 40 days (11%) followed by a gradual decline to 6% at 100 days. Following 20 dyas of treatment with Bromocriptin beginning at 20 days serum PRL was suppressed and SB of LH to the Leydig cells was significantly decreased, whereas SB of PRL and FSH was unaffected. These studies suggest that despite decreases in serum PRL, the number of PRL and FSH receptors remain unaltered. On the contrary, LH receptors in the rat testis are modulated by changes in serum PRL.
研究了不同年龄大鼠腹侧和背外侧前列腺以及睾丸间质细胞和曲细精管上催乳素(PRL)和促性腺激素的特异性结合位点。发现PRL结合位点在腹侧前列腺和间质细胞中数量最多。在睾丸间质细胞中,LH结合位点也比FSH结合位点多。从睾丸获得的曲细精管制剂中,FSH位点比LH位点多。间质细胞中PRL的特异性结合(SB)在45天时达到最大值(4%),而LH在70天时达到最大值,为12%。在两种制剂中,FSH的SB在20至40天之间呈现平台期(11%),随后在100天时逐渐下降至6%。从20天开始用溴隐亭治疗20天后,血清PRL受到抑制,LH与间质细胞的SB显著降低,而PRL和FSH的SB未受影响。这些研究表明,尽管血清PRL降低,但PRL和FSH受体的数量保持不变。相反,大鼠睾丸中的LH受体受血清PRL变化的调节。